Sign in
CompletedNo phase

Improving Walking in Peripheral Artery Disease

Key facts

Who runs it
VA Office of Research and Development
Where
Omaha, United StatesSee the site
Trial code
Status
Completed
People taking part
10 people enrolled
Started
1 Oct 2021
Ended
30 Sept 2024
Type of study
Interventional
Treatments tested
  • Assistive tennis shoes
Record updated
31 October 2025

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • At entry into the study, all patients must:
  • be able to give written, informed consent
  • demonstrate positive history of chronic claudication
  • have an ankle brachial index < 0.90 at rest
  • have a stable blood pressure regimen, stable lipid regimen, stable diabetes regimen and risk factor control for 6 weeks

Who cannot take part

  • rest pain or tissue loss due to peripheral artery disease (Fontaine stage III and IV)
  • acute lower extremity ischemic event secondary to thromboembolic disease or acute trauma
  • walking capacity significantly limited by conditions other than claudication including leg (joint/musculoskeletal, neurologic) and systemic (heart, lung disease) pathology
  • Any potential subjects will be excluded if they have:

Where in United States

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NEOmaha, United States

About the trial

What the trial wants to find out

Peripheral artery disease (PAD) is a cardiovascular disease manifesting from systemic atherosclerosis that blocks the leg arteries and results in insufficient blood flow to the lower extremities. Limb ischemia from PAD is the most common disorder treated within the vascular surgical service of the Omaha Veterans Affairs Medical Center. PAD also accounts for one-third of the operations performed in the VA Medical Centers nationwide. The risk of mortality of Veterans with PAD is substantial; nearly 30% of Veterans with PAD died within 3.8 years of diagnosis. This project aims to establish the feasibility and acceptability of specially designed assistive shoes in patients with PAD and to determine if there are any potential benefits of using these shoes over standard shoes. These assistive shoes may enable patients to carry out desired activities of daily living with less pain and more physical activity. Increasing physical activity will decrease morbidity and mortality. If proven beneficial, the findings will lead to a novel and conservative rehabilitation protocol that directly benefits Veterans nationwide.

The group in the trial

  • Progressive improvement in walking performanceTreatment being tested

    A total of ten patients with peripheral artery disease will be enrolled for this arm and wear the assistive tennis shoes for three-months as an intervention.

    Treatment: Assistive tennis shoes

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Improving Walking in Peripheral Artery Disease Using Specially Designed Assistive Shoes
Record updated
31 October 2025